NeuroSense Therapeutics reports publication of results from their Phase IIa ALS study with PrimeC in a peer-reviewed journal. The article titled: "Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALS," was published in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.

https://www.tandfonline.com/doi/full/10.1080/21678421.2022.2119868

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Neurosense Therapeutics Ltd. published this content on 16 September 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 September 2022 13:09:03 UTC.